-
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo GOLD™ Functional Grade|Leinco|100 mg
- 品牌:Leinco
- 产地:江苏 苏州
- 供应商报价:面议
-
上海来铂生物集团有限公司
更新时间:2025-02-20 15:34:13
-
销售范围售全国
入驻年限第2年
营业执照已审核
- 同类产品其他重组蛋白(12065件)
立即扫码咨询
联系方式:400-966-9005
联系我们时请说明在仪器网(www.yiqi.com)上看到的!
扫 码 分 享 -
为您推荐
详细介绍
您可能感兴趣的产品
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo GOLD™ Functional Grade|Leinco|100 mg
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo GOLD™ Functional Grade|Leinco|25 mg
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo GOLD™ Functional Grade|Leinco|50 mg
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo PLATINUM™ Functional Grade|Leinco|100 mg
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo PLATINUM™ Functional Grade|Leinco|1.0 mg
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo PLATINUM™ Functional Grade|Leinco|5.0 mg
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo PLATINUM™ Functional Grade|Leinco|50 mg
-
重组蛋白Anti-Mouse CD11a (Clone FD441.8) - Purified In vivo PLATINUM™ Functional Grade|Leinco|25 mg
-
重组蛋白Anti-Mouse CD11a (Clone I21/7) - Purified In vivo GOLD™ Functional Grade|Leinco|100 mg
-
重组蛋白Anti-Human CD11a - Purified In vivo GOLD™ Functional Grade|Leinco|100 mg
-
重组蛋白Anti-Mouse CD11a (Clone I21/7) - Purified In vivo GOLD™ Functional Grade|Leinco|1.0 mg
-
重组蛋白Anti-Mouse CD11a (Clone I21/7) - Purified In vivo GOLD™ Functional Grade|Leinco|25 mg
-
厂商推荐产品
-
MycoSEQ 支原体检测套装, 包含(Discriminatory Positive Control 样品制备)|Applied Biosystems|100 reactions 了解详情
-
GlySERIAS Immobilized Microspin |Genovis|5 x 0.2 mg 了解详情
-
FragIT Z – Immobilized FabRICATOR Z|Genovis|5x0.5 mg 了解详情
-
FabRICATOR Preclinical Grade 酶|FabRICATOR Preclinical Grade 1 mg (5 mg/ml)|Genovis|1 mg (5 mg/ml) 了解详情
-
人NK细胞高效版扩增套装(冻存单核细胞来源)|BrilliCellTM –Advanced Human NK Expansion kit (Cyto Cell)|MAINAAN/麦纳安|冻存单核细胞来源人NK细胞无血清基础培养基(含酚红)(1000ml)+基础培养基添加物(20ml)+人NK细胞扩增因子(1.5ml) 了解详情
-
Single Firefly Luciferase Reporter Gene Assay Kit试剂|APExBIO|100T 了解详情
-
Kinase-Lumi化学发光法激酶活性检测试剂盒|Beyotime/碧云天|10000次 了解详情
-